The mission of the CKF is to increase the awareness and understanding of keratoconus, offer support services to keratoconus patients, and to encourage scientific research into the cause(s) and treatment of keratoconus.
Keratoconus is an eye disease that causes the cornea to thin and bulge into a cone-like shape, resulting in blurred vision. Keratoconus is a progressive disease that begins to effect people in their teens and early twenties. Keratoconus occurs in approximately 1 in 1000 people.
Depending on the severity of the disease, there are a handful of keratoconus treatment options available. For people in the early stages of keratoconus, eyeglasses or soft contact lenses can help correct vision. Properly fitted Rigid Gas Permeable contact lenses can be an effective treatment for keratoconus. Intacs are plastic rings that can be inserted into the cornea to help change the shape of the cornea.
Corneal Collagen Cross-Linking (CXL) is the only treatment that can actually halt the progression of the disease. CXL can be combined with a traditional laser treatment or a Topography-guided PRK (T-PRK) treatment to improve vision.